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Purpose: The clinical diagnosis of ocular surface squamous neoplasia is challenging, mostly requiring excisional 
biopsy. Human tumor angiogenesis is characterized by abnormal vessel architecture and transvascular hyper-
permeability. This case report describes features of fluorescein and indocyanine green angiography in a case of 
conjunctival intraepithelial neoplasia. 
Observations: Color photography, optical coherence tomography, fluorescein and indocyanine green angiography 
were performed in a patient with suspected conjunctival intraepithelial neoplasia before excisional biopsy and 
histologic confirmation of clinical diagnosis. Fluorescein dye showed extensive early extravascular dye leakage 
within the limits of the lesion. Indocyanine green dye displayed corneal terminal vessel bulbs with early leakage 
after 70 seconds and showed diffuse intralesional dye leakage after 7 minutes. 
Conclusions: Increased fluorescein and early indocyanine green dye leakage can be used to confirm active 
angiogenesis already in early stages of dysplastic ocular surface squamous neoplasia. Late leakage of indocyanine 
green dye may be due to chronic transvascular hyperpermeability within intrinsic tumor vessels. The leakage 
behaviour of intravenous dyes has the potential to serve as a diagnostic indicator of active growth in dysplastic 
ocular surface neoplastic lesions.   
1. Introduction 
A variety of neoplastic lesions may develop within ocular surface 
tissues, including melanocytic and squamous lesions such as squamous 
papillomas, conjunctival intraepithelial neoplasia (CIN, including car-
cinoma in situ), invasive squamous cell carcinoma (SCC).1 The diagnosis 
of these lesions based on clinical examination is challenging. Despite the 
description of characteristics associated with dysplastic or invasive 
disease such as the presence of feeder vessels or hemorrhage, visible 
intrinsic tumor vasculature, increased size and thickness, it is often 
impossible to reliably exclude dysplastic or malignant disease from 
clinical appearance only.2 Therefore, current diagnosis largely depends 
on invasive excisional biopsy and subsequent histological analysis.3,4 
Vascular alterations, intrinsic tumor vasculature, and inflammation are 
important clinical findings in both ocular surface squamous and mela-
nocytic neoplasia.2,5 We have recently shown, that the vessel diameter 
ratio of afferent to efferent vessels is significantly different between 
benign and malignant melanocytic ocular surface neoplasia (OSN). 
Using ICGA, we have also shown, that the angiographic filling time is 
significantly shorter in benign and non-invasive compared to invasive 
melanocytic and squamous cell OSN.4 It is known, that tumor angio-
genesis in neoplastic tissue is associated with chronic transvascular 
hyperpermeability.6 The angiographic study of intravenous dye leakage 
may therefore allow the assessment of transvascular hyperpermeability 
in OSN for the purpose of improved clinical grading of OSN. 
1.1. Case report 
A 73 year-old male caucasian patient was referred to our ocular 
surface clinic with a suspected diagnosis of conjunctival intraepithelial 
neoplasia in his right eye, which was incidentally diagnosed during a 
routine ophthalmologic visite. Visual acuity was 0.9 on a decimal scale. 
Clinical examination by slit lamp biomicroscopy revealed diffuse greyish 
inferotemporal conjunctival opacity involving 4 limbal clock hours and 
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extending 3 mm onto the cornea, which was accompanied by intrale-
sional neovascularization forming vascular bulbs along the centripetal 
corneal lesion border (Fig. 1). A clinical diagnosis of CIN was made and 
the lesion was imaged using color photography, ICG and fluorescein 
angiography and high-resolution optical coherence tomography (HR- 
OCT) using the HRA Spectralis imaging system (Heidelberg Engineering, 
Heidelberg, Germany). For angiography, single images were taken every 
5 seconds for 2 minutes and then every minute for up to 10 minutes. 
Imaging was performed with approval by the Ethics Committee of the 
Medical University of Innsbruck under vote number AN2015-0287 356/ 
4.8. HR-OCT confirmed an intraepithelial lesion without destruction of 
Bowman membrane and with a maximum thickness of 220 μm (Fig. 2A). 
Fluorescein dye readily leaked from vasculature within the first minute 
post injection, with leaked fluorescent dye clearly demarcating the 
clinical extent of the lesion. On ICG angiography, early dye leakage 
occurred in terminal vessel bulbs along the central corneal border of the 
lesion. Seven minutes post injection, late ICG leakage occurred diffusely 
in the lesion, but not from the surrounding conjunctival vasculature 
(Fig. 2B–D). The lesion was subsequently excised in a no touch double 
freeze technique. Briefly, the corneal lesion was excised by lamellar 
keratectomy. Then a line of haemostasis with cautery was made at 2mm 
from the conjunctival lesion and the lesion was excised entirely along 
this line with blunt dissection underneath the lesion. 100% alcohol was 
applied to the whole base for 1 minute. Postoperative corneal re- 
epithelialization was complete after seven days. Histologic work-up 
confirmed a diagnosis of a completely excised conjunctival CIN with 
high-grade dysplasia. Meanwhile, the patient has been followed up for 6 
months without signs of clinical recurrence. 
Fig. 1. A. Biomicroscopic color photograph of conjunctival intraepithelial neoplasia. B. High magnification color photograph showing terminal vascular bulbs 
(arrows) encroaching onto the cornea within the lesion. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of 
this article.) 
Fig. 2. A. High resolution optical coherence tomographic scan of the lesion confirming the intraepithelial location without corneal stromal involvement. Maximum 
lesional thickness of 220 μm. B. Early fluorescein angiogram (1.5 minutes post injection) depicting diffuse dye leakage within the neoplastic tissue, accentuated in the 
terminal vascular bulbs on the centripetal border of the lesion. C. Early indocyanine green (ICG, 1.5 minutes post injection) angiogram showing leakage accentuated 
in the terminal vascular bulbs on the centripetal border of the lesion. D. Late ICG angiogram (9 minutes post injection) showing diffuse dye leakage within the borders 
of the lesion, but not in surrounding conjunctival tissue. E. Control ICG angiogram of the temporal conjunctiva at 9 minutes post injection. (For interpretation of the 
references to color in this figure legend, the reader is referred to the Web version of this article.) 
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2. Discussion 
Fluorescein dye under physiologic circumstances readily leaks from 
healthy corneal and conjunctival blood vessels during intravenous 
angiography. It is particularly useful for measuring the time to leakage 
of corneal neovascularization providing a reliable indication of vessel 
maturity.7 ICG is highly (98%) protein bound with no early leakage from 
corneal or conjunctival vessels and enables imaging and delineation of 
ocular surface vessels including feeder vessels and intrinsic tumor 
vasculature in OSN.4,8 We have, however, shown that it leaks from 
immature vessels during active angiogenesis, most likely due to fenes-
trations in terminal vascular loops with yet incomplete pericyte 
coverage and intercellular adhesions.9 We have also observed ICG 
leakage from conjunctival vessels in states of ocular surface 
inflammation.10 
While vasculature in neoplastic tissue is knowingly characterized by 
decreased regularity and vessel hierarchy, shunt vessel formation,11 
tumor vessels also display a defective endothelial barrier function, 
incomplete or absent pericyte coverage or basement membrane irregu-
larities, leading to transvascular hyperpermeability in tumors.12 
This may be reflected by the observed early and increased fluorescein 
leakage and late diffuse ICG leakage compared to surrounding 
conjunctival vessels in the present patient. The focal early leakage of ICG 
in terminal vascular bulbs can be attributed to immature vessels in 
active angiogenesis along the centripetal extension of the growing 
lesion.9 This interpretation is encouraged by results of a recent pilot 
investigation showing that ICG leakage behaviour from vessels in mel-
anocytic OSN differs between conjunctival naevi and conjunctival 
melanoma.13 Our interpretation is limited by the fact that we cannot 
exclude inflammation as a contributing factor known to be associated 
with conjunctival and corneal early fluorescein and late ICG dye 
leakage. There were, however, no clinically visible signs of ocular sur-
face inflammation in the affected eye as seen in Fig. 1. Our results 
suggest the use of ICGA as an additional diagnostic method to evaluate 
OSN lesions suspecting of malignancy, along with clinical observation 
and impression cytology.14 The additional information provided by 
angiography may aid in the clinical decision for primary surgical or 
medical treatment as with retinoic acid or interferon alpha 2 b.15,16 
3. Conclusion 
The here presented observation of extravascular dye leakage of ICG 
from intrinsic tumor vessels in a case of CIN requires a systematic 
investigation with immunohistopathologic correlation. Angiography 
may aid in the non-excisional diagnostic evaluation and grading of OSN, 
potentially reducing the need for excisional biopsy in a proportion of 
patients. 
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